• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

袖状肺叶切除术治疗非小细胞肺癌患者的切缘状态的结果。

The outcomes of margin status after sleeve lobectomy for patients of non-small cell lung cancer.

机构信息

Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.

Huai'an First People's Hospital, Nanjing Medical University, Huai'an, China.

出版信息

Thorac Cancer. 2022 Jun;13(11):1664-1675. doi: 10.1111/1759-7714.14441. Epub 2022 May 5.

DOI:10.1111/1759-7714.14441
PMID:35514130
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9161335/
Abstract

BACKGROUND

Sleeve lobectomy is recognized as an alternative surgical operation to pneumonectomy because it preserves the most pulmonary function and has a considerable prognosis. In this study, we aimed to investigate the implications of residual status for patients after sleeve lobectomy.

METHODS

In this retrospective cohort study, we summarized 58 242 patients who underwent surgeries from 2015 to 2018 in Shanghai Chest Hospital and found 456 eligible patients meeting the criteria. The status of R2 was excluded. The outcomes were overall survival (OS) and recurrence-free survival (RFS). We performed a subgroup analysis to further our investigation.

RESULTS

After the propensity score match, the baseline characteristic was balanced between two groups. The survival analysis showed no significant difference of overall survival and recurrence-free survival between R0 and R1 groups (OS: p = 0.053; RFS: p = 0.14). In the multivariate Cox analysis, we found that the margin status was not a dependent risk factor to RFS (p = 0.119) and OS (p = 0.093). In the patients of R1, N stage and age were closely related to OS, but we did not find any significant risk variable in RFS for R1 status. In the subgroup analysis, R1 status may have a worse prognosis on patients with more lymph nodes examination. On further investigation, we demonstrated no differences among the four histological types of margin status.

CONCLUSION

In our study, we confirmed that the margin status after sleeve lobectomies was not the risk factor to prognosis. However, patients with more lymph nodes resection should pay attention to the margin status.

摘要

背景

袖状肺叶切除术因能保留更多的肺功能且预后较好而被认为是全肺切除术的替代手术。本研究旨在探讨袖状肺叶切除术后患者残端状态的意义。

方法

本回顾性队列研究汇总了 2015 年至 2018 年在上海胸科医院接受手术的 58242 例患者,发现符合条件的 456 例患者符合标准。排除 R2 状态。结果为总生存(OS)和无复发生存(RFS)。我们进行了亚组分析以进一步研究。

结果

在倾向评分匹配后,两组的基线特征平衡。生存分析显示 R0 与 R1 组之间 OS 和 RFS 无显著差异(OS:p=0.053;RFS:p=0.14)。在多变量 Cox 分析中,我们发现切缘状态不是 RFS(p=0.119)和 OS(p=0.093)的独立危险因素。在 R1 患者中,N 分期和年龄与 OS 密切相关,但我们未发现 R1 状态对 RFS 的任何显著风险变量。在亚组分析中,R1 状态可能对接受更多淋巴结检查的患者预后更差。进一步研究表明,切缘状态在四种组织学类型中无差异。

结论

在本研究中,我们证实袖状肺叶切除术后的切缘状态不是预后的危险因素。然而,切除更多淋巴结的患者应注意切缘状态。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cc3/9161335/122a4d30305d/TCA-13-1664-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cc3/9161335/58cfc98ae58b/TCA-13-1664-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cc3/9161335/52e8249d56bf/TCA-13-1664-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cc3/9161335/378c64fdbe08/TCA-13-1664-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cc3/9161335/6d9534083d1b/TCA-13-1664-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cc3/9161335/122a4d30305d/TCA-13-1664-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cc3/9161335/58cfc98ae58b/TCA-13-1664-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cc3/9161335/52e8249d56bf/TCA-13-1664-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cc3/9161335/378c64fdbe08/TCA-13-1664-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cc3/9161335/6d9534083d1b/TCA-13-1664-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cc3/9161335/122a4d30305d/TCA-13-1664-g001.jpg

相似文献

1
The outcomes of margin status after sleeve lobectomy for patients of non-small cell lung cancer.袖状肺叶切除术治疗非小细胞肺癌患者的切缘状态的结果。
Thorac Cancer. 2022 Jun;13(11):1664-1675. doi: 10.1111/1759-7714.14441. Epub 2022 May 5.
2
Local control of disease related to lymph node involvement in non-small cell lung cancer after sleeve lobectomy compared with pneumonectomy.与全肺切除术相比,袖状肺叶切除术后非小细胞肺癌淋巴结受累相关疾病的局部控制情况。
Ann Thorac Surg. 2005 Apr;79(4):1153-61; discussion 1153-61. doi: 10.1016/j.athoracsur.2004.09.011.
3
Sleeve lobectomy as an alternative to pneumonectomy in patients with operable lung cancer.袖状肺叶切除术作为可切除肺癌患者的全肺切除术替代方案。
Neoplasma. 2013;60(1):62-7. doi: 10.4149/neo_2013_009.
4
Morbidity, mortality, and long-term survival after sleeve lobectomy for non-small cell lung cancer.非小细胞肺癌袖状肺叶切除术后的发病率、死亡率和长期生存率
Eur J Cardiothorac Surg. 2007 Jan;31(1):95-102. doi: 10.1016/j.ejcts.2006.10.031. Epub 2006 Nov 28.
5
Survival related to lymph node involvement in lung cancer after sleeve lobectomy compared with pneumonectomy.与全肺切除术相比,袖状肺叶切除术后肺癌患者淋巴结受累情况与生存的关系。
J Thorac Cardiovasc Surg. 2000 Apr;119(4 Pt 1):814-9. doi: 10.1016/S0022-5223(00)70018-3.
6
Long-Term Results for Clinical Stage IA Lung Cancer: Comparing Lobectomy and Sublobar Resection.临床ⅠA 期肺癌的长期结果:肺叶切除术与亚肺叶切除术比较。
Ann Thorac Surg. 2018 Aug;106(2):375-381. doi: 10.1016/j.athoracsur.2018.02.049. Epub 2018 Mar 23.
7
Surgical outcomes of sleeve resections performed for non-small cell lung cancer; A single center experience.非小细胞肺癌袖状切除术的手术结果:单中心经验
Niger J Clin Pract. 2020 Jun;23(6):829-834. doi: 10.4103/njcp.njcp_603_18.
8
Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.对比解剖性肺段切除术与肺叶切除术治疗临床ⅠA 期肺腺癌的肿瘤学结果:多中心研究中的倾向性评分匹配分析。
J Thorac Cardiovasc Surg. 2013 Aug;146(2):358-64. doi: 10.1016/j.jtcvs.2013.02.008. Epub 2013 Mar 8.
9
Sleeve lobectomy for non-small cell lung cancer with N1 nodal disease does not compromise survival.袖状肺叶切除术治疗伴有 N1 淋巴结转移的非小细胞肺癌并不影响生存。
Ann Thorac Surg. 2014 Jan;97(1):230-5. doi: 10.1016/j.athoracsur.2013.09.016. Epub 2013 Nov 6.
10
[Safety and long-term outcome of sleeve lobectomy for non-small cell lung cancer].[非小细胞肺癌袖状肺叶切除术的安全性及长期预后]
Ai Zheng. 2009 Aug;28(8):868-71. doi: 10.5732/cjc.009.10028.

本文引用的文献

1
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
2
Feasibility of sleeve lobectomy after neo-adjuvant chemo-immunotherapy in non-small cell lung cancer.新辅助化疗免疫治疗后非小细胞肺癌行袖状肺叶切除术的可行性
Transl Lung Cancer Res. 2020 Jun;9(3):761-767. doi: 10.21037/tlcr-20-539.
3
Clinical outcomes of microscopic residual disease after bronchial sleeve resection for non-small cell lung cancer.
非小细胞肺癌支气管袖状切除术后微小残留病灶的临床结局
J Thorac Cardiovasc Surg. 2020 Feb 29. doi: 10.1016/j.jtcvs.2020.02.079.
4
Bronchus Anastomosis Healing Depending on Type of Neoadjuvant Therapy.支气管吻合口愈合取决于新辅助治疗的类型。
Ann Thorac Surg. 2020 Mar;109(3):879-886. doi: 10.1016/j.athoracsur.2019.10.049. Epub 2019 Dec 13.
5
The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for Residual Tumor Descriptors for Non-Small Cell Lung Cancer.IASLC 肺癌分期项目:非小细胞肺癌切缘状态分析及残余肿瘤描述符建议。
J Thorac Oncol. 2020 Mar;15(3):344-359. doi: 10.1016/j.jtho.2019.10.019. Epub 2019 Nov 13.
6
Sleeve Lobectomy for Non-Small Cell Lung Cancers: Predictive CT Features for Resectability and Outcome Analysis.袖状肺叶切除术治疗非小细胞肺癌:预测可切除性和预后分析的 CT 特征。
AJR Am J Roentgenol. 2019 Oct;213(4):807-816. doi: 10.2214/AJR.19.21258. Epub 2019 Jun 5.
7
Does Induction Therapy Increase Anastomotic Complications in Bronchial Sleeve Resections?诱导治疗会增加支气管袖状切除术中的吻合口并发症吗?
World J Surg. 2019 May;43(5):1385-1392. doi: 10.1007/s00268-019-04908-0.
8
Outcomes of neoadjuvant concurrent chemoradiotherapy followed by surgery for non-small-cell lung cancer with N2 disease.N2期非小细胞肺癌新辅助同步放化疗后手术的疗效
Lung Cancer. 2016 Jun;96:56-62. doi: 10.1016/j.lungcan.2016.03.016. Epub 2016 Mar 29.
9
Sleeve lobectomy after induction chemoradiotherapy.诱导放化疗后行袖状肺叶切除术。
Eur J Cardiothorac Surg. 2012 May;41(5):1052-8. doi: 10.1093/ejcts/ezr184. Epub 2012 Jan 4.
10
The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.新辅助放化疗后,袖状肺叶切除术后围手术期吻合口并发症的发生率并未增加。
Ann Thorac Surg. 2009 Sep;88(3):945-50; discussion 950-1. doi: 10.1016/j.athoracsur.2009.05.084.